Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: January 21, 2022

DrugPatentWatch Database Preview

Details for Patent: 6,294,540

Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,294,540
Title: Carbocyclic nucleoside hemisulfate and its use in treating viral infections
Abstract:The hemisulfate salt of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene- 1-methanol or a solvate of it is used in the treatment of viral infections.
Inventor(s): Brodie; Alastair Couper (London, GB), Jones; Martin Francis (Kneloworth, GB), Seager; John Frederick (Ware, GB), Wallis; Christopher John (Rayston, GB)
Assignee: Glaxo Wellcome Inc. (Research Triangle Park, NC)
Application Number:09/423,982
Patent Claim Types:
see list of patent claims
Compound; Use; Composition; Formulation; Dosage form; Process;

Drugs Protected by US Patent 6,294,540

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,294,540

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9709945May 17, 1997
PCT Information
PCT FiledMay 14, 1998PCT Application Number:PCT/EP98/02835
PCT Publication Date:November 26, 1998PCT Publication Number: WO98/52949

International Family Members for US Patent 6,294,540

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 2009 ⤷  Try it Free
Argentina 012702 ⤷  Try it Free
Argentina 015668 ⤷  Try it Free
Argentina 059120 ⤷  Try it Free
Austria 259811 ⤷  Try it Free
Australia 739953 ⤷  Try it Free
Australia 7765598 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.